The role of 21-hydroxylase in the pathogenesis of adrenal masses: Review of the literature and focus on our own experience
The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
An exaggerated response of 17- hydroxyprogesterone (17-OHP) to exogenous ACTH stimulation has been found in 30 to 70% of patients with incidentally discovered adrenal tumors, supporting the concept that congenital 21- hydroxylase deficiency may be a predisposing factor for adrenocortical tumorigenesis. Decreased expression of 21-hydroxylase gene has been observed in sporadic non-functioning adrenocortical adenomas and adrenocortical carcinomas, in agreement with the reduced steroidogenic activity found in these types of tumors. Screening studies for the presence of mutations in CYP21A2 gene, encoding 21-hydroxylase, in patients with sporadic adrenocortical tumors yielded discordant results. Overall, a higher frequency of germline 21-hydroxylase mutation carriers has been found among patients with adrenal tumors, including incidentalomas, than in the general population. However, the presence of mutations did not correlate with endocrine test results and tumor mass features, suggesting that 21-hydroxylase deficiency does not represent a relevant mechanism in adrenal tumorigenesis. Mechanisms leading to reduced 21-hydroxylase expression and activity are still unknown.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adrenal carcinomas are rarely found in persons with CAH (270), and only a single pediatric case has been reported (271).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [270]
In the citing paper
“However, the co-occurrence of a rare tumor and a fairly common genetic syndrome make this association unconvincing at this point (76).”
From Adrenocortical carcinoma (2014) · cites this paper as [76]
Citations
Cites
Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones
Payne, A. H., & Hales, D. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0030 · Cited by 1,766
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
Incidentally Discovered Adrenal Masses*
KLOOS, R. T., GROSS, M. D., FRANCIS, I. R., KOROBKIN, M., & SHAPIRO, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-4-460 · Cited by 828
Congenital adrenal hyperplasia
El-Maouche, D., Arlt, W., & Merke, D. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31431-9 · Cited by 669
Prevalence and natural history of adrenal incidentalomas
Barzon, L., Sonino, N., Fallo, F., Palu, G., & Boscaro, M. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490273 · Cited by 642
Congenital adrenal hyperplasia.
Merke, D. P., & Bornstein, S. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66736-0 · Cited by 628
Risk Factors and Long-Term Follow-Up of Adrenal Incidentalomas1
Barzon, L., Scaroni, C., Sonino, N., Fallo, F., Paoletta, A., & Boscaro, M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5444 · Cited by 254
Adrenocorticotropin insensitivity syndromes
Clark, A. J. L., & Weber, A. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0351 · Cited by 234
Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia.
Jaresch, S., Kornely, E., Kley, H. K., & Schlaghecke, R. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.3.1311000 · Cited by 227
Transcriptional regulation of steroid hydroxylase genes by corticotropin
John, M. E., John, M. C., Boggaram, V, Simpson, E. R., & Waterman, M. R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4715 · Cited by 217
Incidentally Discovered Adrenal Tumors: Endocrine and Scintigraphic Correlates1
Barzon, L., Scaroni, C., Sonino, N., Fallo, F., Gregianin, M., Macri’, C., & Boscaro, M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.1.4501 · Cited by 177
Transcriptional corepression by SHP: molecular mechanisms and physiological consequences
Båvner, A., Sanyal, S., Gustafsson, J.-Å., & Treuter, E. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.10.005 · Cited by 159
Profiling transcript levels for steroidogenic enzymes in fetal tissues
Pezzi, V., Mathis, J. M., Rainey, W. E., & Carr, B. R. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2003.07.006 · Cited by 156
Pro-γ-melanocyte-stimulating hormone cleavage in adrenal gland undergoing compensatory growth
Lowry, P. J., Silas, L., McLean, C., Linton, E. A., & Estivariz, F. E. (1983) · Nature · doi:10.1038/306070a0 · Cited by 145
Incidentally Discovered Adrenal Tumors: Endocrine and Scintigraphic Correlates
Barzon, L. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.1.55 · Cited by 140
Sirianni, R., Seely, J., Attia, G., Stocco, D., Carr, B., Pezzi, V, & Rainey, W. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.174r013 · Cited by 138
Abnormalities of endocrine function in patients with clinically silent adrenal masses.
Ambrosi, B., Peverelli, S., Passini, E., Re, T., Ferrario, R., Colombo, P., Sartorio, A., & Faglia, G. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1320422 · Cited by 136
Expression Profiles for Steroidogenic Enzymes in Adrenocortical Disease
Bassett, M. H., Mayhew, B., Rehman, K., White, P. C., Mantero, F., Arnaldi, G., Stewart, P. M., Bujalska, I., & Rainey, W. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0836 · Cited by 125
DIAGNOSIS AND MANAGEMENT OF ADRENAL INCIDENTALOMAS
BARZON, L., & BOSCARO, M. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67888-3 · Cited by 113
Narasaka, T., Suzuki, T., Moriya, T., & Sasano, H. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00445-7 · Cited by 109
Reincke, M., Mora, P., Beuschlein, F., Arlt, W., Chrousos, G. P., & Allolio, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.9.4211 · Cited by 92
Simonian, M. H., & Gill, G. N. (1981) · Endocrinology · doi:10.1210/endo-108-5-1769 · Cited by 91
Ravichandran, R. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.5.1776 · Cited by 84
Carriers of 21-Hydroxylase Deficiency Are Not at Increased Risk for Hyperandrogenism
Knochenhauer, E. S. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.479 · Cited by 81
Different patterns of steroid secretion in patients with adrenal incidentaloma
Terzolo, M. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.2.740 · Cited by 76
Montanaro, D., Maggiolini, M., Recchia, A. G., Sirianni, R., Aquila, S., Barzon, L., Fallo, F., Andò, S., & Pezzi, V (2005) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01806 · Cited by 73
Shannon, M. F., Pell, L. M., Lenardo, M. J., Kuczek, E. S., Occhiodoro, F. S., Dunn, S. M., & Vadas, M. A. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.6.2950 · Cited by 66
Graham, D. J., & McHenry, C. R. (1998) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30243-6 · Cited by 65
Lefebvre, H., Duparc, C., Chartrel, N., Jegou, S., Pellerin, A., Laquerriere, A., Ivell, R., Vaudry, H., & Kuhn, J.-M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-030014 · Cited by 65
Balsamo, Cacciari, E., Baldazzi, L., Tartaglia, L., Cassio, A., Mantovani, V., Piazzi, S., Cicognani, A., Pirazzoli, P., Mainetti, B., et al. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01048.x · Cited by 65
Seppel, T., & Schlaghecke, R. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02575.x · Cited by 63
Sasano, H., SUZUKI, T. A., Nagura, H., & Nishikawa, T. (1993) · Human Pathology · doi:10.1016/0046-8177(93)90088-x · Cited by 63
Coulter, C. L., & Jaffe, R. B. (1998) · Endocrinology · doi:10.1210/endo.139.12.6333 · Cited by 62
Bauman, A. (1982) · JAMA · doi:10.1001/jama.1982.03330230052032 · Cited by 56
Wijesuriya, S. D., Zhang, G., Dardis, A., & Miller, W. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.38097 · Cited by 54
Adrenal Myelolipoma Associated With Endocrine Dysfunction: Review of the Literature
Umpierrez, M. B., Fackler, S., Umpierrez, G. E., & Rubin, J. E. (1997) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40233-2 · Cited by 52
Beuschlein, F., Schulze, E., Mora, P., Gensheimer, H.-P., Maser-Gluth, C., Allolio, B., & Reincke, M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.7.4965 · Cited by 50
Bird, I. M., Mason, J. I., & Rainey, W. E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.5.4825 · Cited by 49
Tee, M. K., Babalola, G. O., Aza-Blanc, P., Speek, M., Gitelman, S. E., & Miller, W. L. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.11.2109 · Cited by 47
Racz, K. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.3.677 · Cited by 43
Kimura, E., Sonobe, M. H., Armelin, M. C. S., & Armelin, H. A. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.11.8114760 · Cited by 42
Bornstein, S. R., Ehrhart, M., Scherbaum, W. A., & Pfeiffer, E. F. (1990) · Cell and Tissue Research · doi:10.1007/bf00297501 · Cited by 39
Patocs, A., Toth, M., Barta, C., Sasvari-Szekely, M., Varga, I., Szucs, N., Jakab, C., Glaz, E., & Racz, K. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1470349 · Cited by 38
Impairment of 11β-hydroxylase but not 21-hydroxylase in adrenal 'incidentalomas'
Reincke, M., Peter, M., Sippell, W. G., & Allolio, B. (1997) · European Journal of Endocrinology · doi:10.1530/eje.0.1360196 · Cited by 36
Steroidogenesis in Aldosterone-Producing Adenoma Revisited by Transcriptome Analysis
Assié, G., Auzan, C., Gasc, J., Baviéra, E. E., Balaton, A. J., Elalouf, J., Jeunemaître, X., Plouin, P., Corvol, P. L., & Clauser, É. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1309 · Cited by 35
Dall’Asta, C., Barbetta, L., Libé, R., Passini, E., & Ambrosi, B. (2002) · Hormone Research in Paediatrics · doi:10.1159/000058381 · Cited by 34
Liu, J., Li, X.-D., Vaheri, A. I., & Voutilainen, R. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01560 · Cited by 34
Incidentally Discovered Adrenal Tumors: Endocrine and Scintographic Correlates
Barzon, L., Scaroni, C., Sonino, N., Fallo, F., Gregianin, M., Macri, C., & Boscaro, M. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)62838-6 · Cited by 34
Baumgartner‐Parzer, S. M., Pauschenwein, S., Waldhäusl, W., Pölzler, K., Nowotny, P., & Vierhapper, H. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01299.x · Cited by 32
ACTH 1-24 inhibits proliferation of adrenocortical tumors in vivo
Zwermann, O., Schulte, D. M., Reincke, M., & Beuschlein, F. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01983 · Cited by 31
Bird, I. M. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.5.1592 · Cited by 31
Willenberg, H. S., Haase, M., Papewalis, C., Schott, M., Scherbaum, W. A., & Bornstein, S. R. (2005) · Neuroendocrinology · doi:10.1159/000093126 · Cited by 30
17-hydroxyprogesterone response to ACTH in bilateral and monolateral adrenal incidentalomas
Bernini, G., Brogi, G., Vivaldi, M. S., Argenio, G. R., Sgrò, M., Moretti, A., & Salvetti, A. (1996) · Journal of Endocrinological Investigation · doi:10.1007/bf03347878 · Cited by 30
Adrenal Myelolipoma Associated With Endocrine Dysfunction: Review of the Literature
UMPIERREZ, M. B., FACKLER, S., Umpierrez, G. E., et al. (1997) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199711000-00012 · Cited by 30
The Adrenal Incidentaloma: A Pediatric Perspective
LIGHTNER, E. S. (1993) · American Journal of Diseases of Children · doi:10.1001/archpedi.1993.02160360016002 · Cited by 28
No overrepresentation of congenital adrenal hyperplasia in patients with adrenocortical tumours
Kjellman, M., Holst, M., Bäckdahl, M., Larsson, C., Farnebo, L., & Wedell, A. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00655.x · Cited by 26
Tóth, M., Rácz, K., Adleff, V., Varga, I., Fütő, L., Jakab, C., Karlinger, K., Kiss, R., & Gláz, E. (2000) · Journal of Endocrinological Investigation · doi:10.1007/bf03343725 · Cited by 24
Nagasaka, S., Kubota, K., Motegi, T., Hayashi, E., Ohta, M., Takahashi, K., Takahashi, T., Iwasaki, Y., Koike, M., Nishikawa, T., et al. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.631456.x · Cited by 23
Falhammar, H., & Thoren, M. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03347226 · Cited by 23
Congenital Adrenal Hyperplasia Diagnosed in a Man During Workup for Bilateral Adrenal Masses
Mokshagundam, S. P. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.11.1389 · Cited by 21
Shannon, M. F., Pell, L. M., Lenardo, M. J., et al. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.6.2950-2959.1990 · Cited by 20
Sadoul, J., Kézachian, B., Altare, S., Hadjali, Y., & Canivet, B. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1410238 · Cited by 18
Lee, H., Lee, Y., & Chang, C. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5342 · Cited by 17
Endoh, A. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)00224-4 · Cited by 13
Adrenal tumors associated with inadequately treated congenital adrenal hyperplasia.
Wang, J., Bissada, M. A., Williamson, H. O., YAKOUT, H. H., & Bissada, N. K. (2002) · PubMed · Cited by 11
Bauman, A. (1982) · JAMA · doi:10.1001/jama.248.23.3140 · Cited by 11
Adrenal Incidentalomas: Adrenal Hemangioma in a Patient With Congenital Adrenal Hyperplasia
Pignatelli, D., Vendeira, P., & CABRAL, A. C. (1998) · Southern Medical Journal · doi:10.1097/00007611-199808000-00018 · Cited by 11
Adrenocortical Adenoma Associated with Inadequately Treated Congenital Adrenal Hyperplasia
Kurtoğlu, S., Atabek, M. E., Kcskin, M., & Patıroglu, I. E. (2003) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2003.16.9.1311 · Cited by 10
Macronodular congenital adrenal hyperplasia in an adult with female pseudohermaphroditism
Norris, A. M., O'Driscoll, J. B., & Mamtora, H. (1996) · European Radiology · doi:10.1007/bf00182473 · Cited by 7
A case report of virilising adrenal cortical carcinoma.
Gk, D., Hh, D., Choubey, B. S., & Kher, A. A. M. (1981) · PubMed · Cited by 6
Adrenal incidentalomas: adrenal hemangioma in a patient with congenital adrenal hyperplasia.
Pignatelli, D., Vendeira, P., & Ac, C. (1998) · PubMed · Cited by 6
Ogo, A., Haji, M., Yanase, T., Kato, K., & Nawata, H. (1991) · Journal of Endocrinological Investigation · doi:10.1007/bf03347937 · Cited by 2
Cited by
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
“Adrenal carcinomas have rarely been reported in adults (151) and in only two pediatric patients with CAH (152, 153).”
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Else, T., Kim, A. C., Sabolch, A., Raymond, V. M., Kandathil, A., Caoili, E. M., Jolly, S., Miller, B. S., Giordano, T. J., & Hammer, G. D. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1029 · Cited by 892
“However, the co-occurrence of a rare tumor and a fairly common genetic syndrome make this association unconvincing at this point (76).”
BackgroundPW, S., W, A., RJ, A., LS, B., GS, C., DP, M., HFL, M.-B., WL, M., MH, M., SE, O., et al. (2019) · Yearbook of Paediatric Endocrinology · doi:10.1530/ey.16.8.5 · Cited by 300
Guengerich, F. P. (2015) · Springer eBooks · doi:10.1007/978-3-319-12108-6_9 · Cited by 214
Metadata
- Authors
- Barzon, L., Maffei, P., Sonino, N., Pilon, C., Baldazzi, L., Balsamo, A., Del Maschio, O., Masi, G., Trevisan, M., Pacenti, M., & Fallo, F.
- Affiliations
- University of Padua (IT)
- University of Bologna (IT)
- Corresponding author
- Fallo, F.
- Venue
- Journal of Endocrinological Investigation
- Published
- 2007-07
- Volume
- 30
- Issue
- 7
- Pages
- 615-623
- ISSN
- 0391-4097 (ISSN-L)
- 1720-8386
- OpenAlex
- W2084360091
- Cited by
- 24
- References
- 71
- Citations by year
- 2026: 2 · 2024: 1 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 1 · 2014: 3 · 2013: 1 · 2012: 2
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Endocrinological Investigation (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- Istituto Oncologico Veneto
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Keywords
- 21-hydroxylase, CYP21A2, congenital adrenal hyperplasia, adrenal tumors, adrenal adenoma, adrenocortical carcinoma, adrenal incidentaloma, 17-hydroxyprogesterone, ACTH stimulation test, adrenocortical tumorigenesis, germline mutations, steroidogenesis
- MeSH terms
- Adrenal Gland Neoplasms, Adrenal Hyperplasia, Congenital, Glucocorticoids, Humans, Steroid 21-Hydroxylase, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Adrenocortical Carcinoma, 17-alpha-Hydroxyprogesterone, Incidental Findings
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.